Publikation:

Delivery of Tumor Antigens to Dendritic Cells Using Biodegradable Microspheres

Lade...
Vorschaubild

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

2004

Autor:innen

Waeckerle-Men, Ying
Gander, Bruno
Gröttrup, Marcus

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Beitrag zu einem Sammelband
Publikationsstatus
Published

Erschienen in

LUDEWIG, Burkhard, Matthias W. HOFFMANN. Adoptive Immunotherapy : Methods and Protocols. Totowa, NJ: Humana Press, 2004, pp. 035-046. Methods in Molecular Medicine. 109. ISBN 978-1-58829-406-7. Available under: doi: 10.1385/1-59259-862-5:035

Zusammenfassung

Poly(D,L-lactide-co-glycolide) (PLGA) polymers have been used for the production of biodegradable medical sutures and for controlled drug release for decades. Useful characteristics such as in vivo biodegradability, an adjustable release profile, and the very high encapsulation capacity have stimulated immunologists to explore PLGA microspheres (MS) as antigen delivery systems for vaccination for more than 15 yr. In previous studies aiming at the development of "single-dose" vaccines, direct immunization with PLGA MS containing various antigens induced strong and sustained immune responses. We have observed that human immature monocyte-derived dendritic cells (MoDC) prepared for clinical application are able to internalize high numbers of MS without negative effects on their pivotal properties. Furthermore, PLGA-MS-incorporated antigens are effectively processed for presentation on Major histocompatibility complex (MHC) class I and MHC class II molecules by dendritic cells (DCs) in vitro and induced strong cytotoxic T-lymphocyte (CTL) responses in vivo. Taken together, PLGA MS is a promising delivery vehicle for the improvement of current DC-based tumor vaccine protocols.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Antigen processing, dendritic cells, immunotherapy, microspheres, poly(lactide-co-glycolide), vaccine delivery.

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690WAECKERLE-MEN, Ying, Bruno GANDER, Marcus GRÖTTRUP, 2004. Delivery of Tumor Antigens to Dendritic Cells Using Biodegradable Microspheres. In: LUDEWIG, Burkhard, Matthias W. HOFFMANN. Adoptive Immunotherapy : Methods and Protocols. Totowa, NJ: Humana Press, 2004, pp. 035-046. Methods in Molecular Medicine. 109. ISBN 978-1-58829-406-7. Available under: doi: 10.1385/1-59259-862-5:035
BibTex
@incollection{WaeckerleMen2004Deliv-22120,
  year={2004},
  doi={10.1385/1-59259-862-5:035},
  title={Delivery of Tumor Antigens to Dendritic Cells Using Biodegradable Microspheres},
  number={109},
  isbn={978-1-58829-406-7},
  publisher={Humana Press},
  address={Totowa, NJ},
  series={Methods in Molecular Medicine},
  booktitle={Adoptive Immunotherapy : Methods and Protocols},
  pages={035--046},
  author={Waeckerle-Men, Ying and Gander, Bruno and Gröttrup, Marcus}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/22120">
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2013-03-22T09:57:59Z</dcterms:available>
    <dc:rights>terms-of-use</dc:rights>
    <dcterms:title>Delivery of Tumor Antigens to Dendritic Cells Using Biodegradable Microspheres</dcterms:title>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2013-03-22T09:57:59Z</dc:date>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dcterms:bibliographicCitation>Adoptive Immunotherapy : Methods and Protocols / ed. by Burkhard Ludewig ... - Totowa, NJ : Humana Press, 2005. - S. 35-46. - (Methods in Molecular Medicine ; 109). - ISBN 978-1-58829-406-7</dcterms:bibliographicCitation>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Gander, Bruno</dc:contributor>
    <dc:contributor>Gröttrup, Marcus</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Waeckerle-Men, Ying</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/22120"/>
    <dcterms:issued>2004</dcterms:issued>
    <dc:creator>Waeckerle-Men, Ying</dc:creator>
    <dc:creator>Gröttrup, Marcus</dc:creator>
    <dc:language>eng</dc:language>
    <dcterms:abstract xml:lang="eng">Poly(D,L-lactide-co-glycolide) (PLGA) polymers have been used for the production of biodegradable medical sutures and for controlled drug release for decades. Useful characteristics such as in vivo biodegradability, an adjustable release profile, and the very high encapsulation capacity have stimulated immunologists to explore PLGA microspheres (MS) as antigen delivery systems for vaccination for more than 15 yr. In previous studies aiming at the development of "single-dose" vaccines, direct immunization with PLGA MS containing various antigens induced strong and sustained immune responses. We have observed that human immature monocyte-derived dendritic cells (MoDC) prepared for clinical application are able to internalize high numbers of MS without negative effects on their pivotal properties. Furthermore, PLGA-MS-incorporated antigens are effectively processed for presentation on Major histocompatibility complex (MHC) class I and MHC class II molecules by dendritic cells (DCs) in vitro and induced strong cytotoxic T-lymphocyte (CTL) responses in vivo. Taken together, PLGA MS is a promising delivery vehicle for the improvement of current DC-based tumor vaccine protocols.</dcterms:abstract>
    <dc:creator>Gander, Bruno</dc:creator>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen